The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADICET BIO INC COM NEW 007002207 162,642 22,779 SH DFND 1 0 22,779 0
CEREBRAS SYSTEMS INC COM CL A 15675D103 22,854,495 128,649 SH DFND 1 0 128,649 0
CONTINEUM THERAPEUTICS INC CL A 21217B100 26,560,502 1,979,173 SH DFND 1 0 1,979,173 0
CVRX INC COM 126638105 7,043,507 4,024,861 SH DFND 1 0 4,024,861 0
FATE THERAPEUTICS INC COM 31189P102 8,008,382 3,379,064 SH DFND 1 0 3,379,064 0
LEGEND BIOTECH CORP SPONSORED ADS 52490G102 16,202,116 814,586 SH DFND 1 0 814,586 0
MEIRAGTX HLDGS PLC COM G59665102 73,051,704 6,641,064 SH DFND 1 0 6,641,064 0
NANOBIOTIX SPONSORED ADS 63009J107 175,238,107 5,623,816 SH DFND 1 0 5,623,816 0
NEUMORA THERAPEUTICS INC. COM 640979100 1,102,639 1,849,445 SH DFND 1 0 1,849,445 0
PROCEPT BIOROBOTICS CORP COM 74276L105 6,521,649 357,939 SH DFND 1 0 357,939 0
PROTAGONIST THERAPEUTICS INC COM 74366E102 345,065,393 2,449,183 SH DFND 1 0 2,449,183 0
RAPPORT THERAPEUTICS INC COM 75383L102 59,959,771 1,784,517 SH DFND 1 0 1,784,517 0
VOR BIOPHARMA INC COM NEW 929033207 1,025,207 53,732 SH DFND 1 0 53,732 0
XENCOR INC COM 98401F105 18,664,147 748,062 SH DFND 1 0 748,062 0
STANDARD BIOTOOLS INC COM 34385P108 231,043 311,967 SH DFND 0 311,967 0